Innovent Biologics, Inc. (IVBXF)
Market Closed
14 Oct, 08:00 PM
OTC PINK 
$
12. 50
+1.13
+9.9384%
$
17.95B Market Cap
- P/E Ratio
- Div Yield
1,022 Volume
0 Eps
$ 11.37
Previous Close Want to track IVBXF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Innovent Biologics, Inc. (IVBXF) Statistics
Valuation metrics
Market Cap 17.95B
Enterprise value 122.42B
Trailing P/E (ttm) 111.27
Forward P/E -
PEG ratio 18.64
Price/Sales (ttm) 8.8
Price/Book (mrq) 6.55
Enterprise Value/Revenue 7.85
Enterprise Value/EBITDA 48.18
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.29K
Average volume (90 days) 1.69K
Price summary
52-Week low 9.1
52-Week high 15.01
Beta -
50-Day moving average 12.78
200-Day moving average 11.37
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.08%
Operating margin 0.12%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 9.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.7
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.59
Total debt (mrq) -
Total Debt/Equity (mrq) 0.11
Current ratio (mrq) 2.68%
Book value per share (mrq) 12.49
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
